EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)ÄquivalenzstudieMultizentrische StudiePragmatische Studie

A Pragmatic Trial of a 6-Month Strategy for Rifampicin-Resistant Tuberculosis

Francesca Conradie, Tasnim Badat, Asanda Poswa, Shakira Rajaram, Shaneen Kooverjee, Gary Maartens, Graeme Meintjes, Jennifer Hughes, H Simon Schaaf, Pauline Howell, Norbert Ndjeka, Patrick P J Phillips

New England Journal of Medicine · 25.06.2026 · 394 (24) · 2429-2439

DOI: 10.1056/nejmoa2503687 ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift New England Journal of Medicine, erschienen am 25.06.2026. Verfasst von Francesca Conradie und 11 weiteren Autor:innen. Beteiligte Einrichtung: Isango Lethemba TB Research Unit, University of the Witwatersrand, Gqeberha, South Africa. Hauptthemen laut MEDLINE: Antitubercular Agents, Mycobacterium tuberculosis, Tuberculosis, Multidrug-Resistant, Tuberculosis, Pulmonary. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: United States Agency for International Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antitubercular AgentsMycobacterium tuberculosisTuberculosis, Multidrug-ResistantTuberculosis, PulmonaryPregnancy Complications, InfectiousAdolescentAdultFemaleHumansMaleYoung AdultClofazimineDiarylquinolinesDrug Therapy, CombinationLevofloxacinLinezolidNitroimidazolesOxazolesRifampinSouth AfricaFluoroquinolonesIsoniazidMicrobial Sensitivity TestsSputumTreatment Outcome

Substanzen

Antitubercular AgentsbedaquilineClofazimineDiarylquinolinesLevofloxacinLinezolidNitroimidazolesOPC-67683OxazolesRifampin

Autor:innen und Institutionen

  • Isango Lethemba TB Research Unit, University of the Witwatersrand, Gqeberha, South Africa.
  • Clinical HIV Research Unit, University of the Witwatersrand, Johannesburg.
  • Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Queen Mary and Barts Health Tuberculosis Centre, Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London.
  • Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.

Förderung

  • United States Agency for International Development

Zitieren

APA

Conradie, F., Badat, T., Poswa, A., Rajaram, S., Kooverjee, S., Maartens, G., Meintjes, G., Hughes, J., Schaaf, H. S., Howell, P., Ndjeka, N., & Phillips, P. P. J. (2026). A Pragmatic Trial of a 6-Month Strategy for Rifampicin-Resistant Tuberculosis. New England Journal of Medicine, 394(24), 2429-2439. https://doi.org/10.1056/nejmoa2503687

Vancouver

Conradie F, Badat T, Poswa A, Rajaram S, Kooverjee S, Maartens G, et al. A Pragmatic Trial of a 6-Month Strategy for Rifampicin-Resistant Tuberculosis. New England Journal of Medicine. 2026;394(24):2429-2439. doi:10.1056/nejmoa2503687

BibTeX
@article{Conradie2026,
  author = {Conradie, Francesca and Badat, Tasnim and Poswa, Asanda and Rajaram, Shakira and Kooverjee, Shaneen and Maartens, Gary and Meintjes, Graeme and Hughes, Jennifer and Schaaf, H Simon and Howell, Pauline and Ndjeka, Norbert and Phillips, Patrick P J},
  title = {A Pragmatic Trial of a 6-Month Strategy for Rifampicin-Resistant Tuberculosis},
  journal = {New England Journal of Medicine},
  year = {2026},
  volume = {394},
  number = {24},
  pages = {2429--2439},
  doi = {10.1056/nejmoa2503687}
}
Kostenlos starten →